Search

everythinglearnresearchcommunity

for

Search:↓

CTP-543 effectively promotes hair regrowth in adults with moderate to severe alopecia areata.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

CTP-543 is generally safe for treating alopecia areata.

Canakinumab's effect on COVID-19 outcomes is unclear.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Anifrolumab improves quality of life and reduces steroid use in lupus patients.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Tofacitinib helped improve symptoms and hair growth in a patient with Aicardi-Goutières syndrome.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Thermography matched the patient's pain levels in a shingles case and might help diagnose shingles without a rash.

COVID-19 can cause significant hair loss.

A girl with Crohn's disease developed hair loss due to her increased medication, a rare side effect seen in some children.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Tofacitinib successfully treated a woman's severe symptoms from a rare autoimmune condition.

Ixekizumab has known and some unexpected side effects.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.